Literature DB >> 31666104

Correction to: The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway.

Sahyun Pak1, Sejun Park2, Yunlim Kim3,4, Jung-Hyuck Park5, Chan-Hee Park5, Kyoung-June Lee6, Choung-Soo Kim3, Hanjong Ahn7.   

Abstract

In the original publication of this article [1], there are mistakes in Fig. 4d. The corrected Fig. 4 should be.

Entities:  

Year:  2019        PMID： 31666104      PMCID： PMC6822452          DOI： 10.1186/s13046-019-1451-1

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN： 0392-9078


Correction to: J Exp Clin Cancer Res (2019) 38: 342 https://doi.org/10.1186/s13046-019-1342-5 In the original publication of this article [1], there are mistakes in Fig. 4d. The corrected Fig. 4 should be:
Fig. 4

.

.
  1 in total

1.  The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway.

Authors:  Sahyun Pak; Sejun Park; Yunlim Kim; Jung-Hyuck Park; Chan-Hee Park; Kyoung-June Lee; Choung-Soo Kim; Hanjong Ahn
Journal:  J Exp Clin Cancer Res       Date:  2019-08-06
  1 in total
  1 in total

Review 1.  Recent advances in targeted drug delivery systems for resistant colorectal cancer.

Authors:  Masoumeh Sharifi-Azad; Marziyeh Fathi; William C Cho; Abolfazl Barzegari; Hamed Dadashi; Mehdi Dadashpour; Rana Jahanban-Esfahlan
Journal:  Cancer Cell Int       Date:  2022-05-19       Impact factor: 6.429
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.